Reflective Functioning and Psychotherapy Processes in MBT
1 other identifier
observational
60
1 country
1
Brief Summary
Borderline personality disorder (BPD) is a pervasive mental disorder characterized by emotional instability, self-destructive behavior, identity problems and unstable relationships. Persons with this disorder usually experience significant distress in terms of depression, anxieties, suicidal behavior, and difficulties in close relationships as well as with work- and social functioning. Recent research has found the prognosis of BPD to be better than previously assumed, and many patients improve from treatment. Mentalization based therapy (MBT) is a specialized evidenced based therapy for patients with BPD. Like for other specialized treatments for this disorder, the outcome of therapy is typically variable, some patients respond well to treatment, whereas others respond less. It is therefore important to understand how treatment works in order to improve therapies and tailor treatment to individual patients. Mentalizing is the ability to understand ourselves and others in terms of mental states, like intentions, feelings, desires, attitudes, and so on, or briefly; the ability to mind own and other's minds. Impaired mentalizing capacity is an assumed core aspect of BPD, underlying many of the symptoms of this disorder. MBT focuses on the patients mentalizing difficulties and is typically offered as a long-term combined treatment program comprising individual and group therapy, as well as psychoeducation. Several studies have documented positive effects of MBT in terms of reduced suicidal behavior, symptoms, interpersonal problems, medication, and health service use. It is assumed that such clinical improvement is made possible by helping the patients to develop their mentalizing abilities. Yet, no study has investigated whether patients' mentalizing capacity changes during MBT, or to what degree outcome of MBT is mediated by improved mentalizing. Mentalizing is, however, a complex phenomenon and difficult to measure. Research in this area has been hampered by a lack of suitable methods. Mentalizing is usually operationalized as Reflective Functioning (RF) assessed by the RF Scale. The gold standard is to apply the RF Scale on the Adult Attachment Interview. However, this is a time consuming and costly method, and there is a need for testing other methods as well. The overall aim of the project is to study treatment processes in MBT for patients with BPD. It focuses on patients' mentalizing difficulties before, during and at the end of therapy. Mentalizing is assessed using different methods. Our main research questions are:
- 1.To what degree does patients' level of RF change during MBT?
- 2.Is there a relationship between RF and outcome of MBT?
- 3.What is the relationship between RF and therapy processes in MBT?
- 4.Is it possible to identify in-session processes that promote mentalizing?
- 5.What is the clinical utility of various methods of RF assessment?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedFirst Posted
Study publicly available on registry
November 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedNovember 8, 2019
November 1, 2019
5.3 years
November 1, 2019
November 6, 2019
Conditions
Outcome Measures
Primary Outcomes (17)
Work and Social Adjustments Scale, WSAS, change during treatment and 3 months follow-up
Work and social adaption
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Global Assessment of Functioning, GAF, change during treatment and 3 months follow-up
psychosocial functioning
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Patient Health Questionnaire, PHQ-9, change during treatment and 3 months follow-up
depression
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Patient Health Questionnaire, GAD-7, change during treatment and 3 months follow-up
anxiety
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Self-harm, self-report, change during treatment and 3 months follow-up
Self-harm
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Suicide attempts, self-report, change during treatment and 3 months follow-up
Suicide attempts
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Circumplex of Interpersonal Problems, CIP, change during treatment and 3 months follow-up
interpersonal problems
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Severity Index of Personality Problems, SIPP-118, change during treatment and 3 months follow-up
personality functioning
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Level of Personality Functioning Scale, LPFS BF, change during treatment and 3 months follow-up
personality functioning
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Difficulties in Emotion Regulation Scale, DERS, change during treatment and 3 months follow-up
emotional regulation
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Toronto Alexithymia Scale, TAS-20, change during treatment and 3 months follow-up
alexithymia
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Reflective functioning based on AAI, change from baseline to 3 months follow-up
reflective functioning
3 months follow-up
Reflective functioning based on the mentalization breakdown interview, change during treatment and 3 months follow-up
reflective functioning
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Reflective functioning based on therapy sessions, change during treatment
reflective functioning
6, 12, 18, 24, 30 and 36 months
Months in work or studies, self report, change during treatment and 3 months follow-up
work functioning
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Experiences in Close relationships, ECR, change during treatment and 3 months follow-up
attachment
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Suicide ideation, change during treatment and 3 months follow-up
Suicide ideation
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Secondary Outcomes (7)
Substance use (from AUDIT and DUDIT), change during treatment and 3 months follow-up
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
EuroQoL, EQ-5D, change during treatment and 3 months follow-up
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Modified Overt Aggression Scale (selected items), change during treatment and 3 months follow
6, 12, 18, 24, 30 and 36 months, and 3 months follow-up
Working Alliance Inventory, WAI, change during treatment
6, 12, 18, 24, 30 and 36 months
Group Questionnaire, GQ, change during treatment
6, 12, 18, 24, 30 and 36 months
- +2 more secondary outcomes
Study Arms (1)
Patients with borderline personality disorder
Patients with borderline personality disorder included in the MBT program
Interventions
Mentalization based therapy is a specialized treatment for patients with borderline personality disorder. The treatment program combines individual and group therapy, as well as psychoeducation
Eligibility Criteria
Patients with borderline personality disorder or significant borderline traits, who are treated in the MBT program at the Personality Outpatient Unit, Oslo University Hospital (OUH).
You may qualify if:
- \- Borderline personality disorder or significant borderline traits
You may not qualify if:
- patients with psychotic disorders as their main problem
- Asperger's syndrome/autism spectrum disorders
- low IQ
- unregulated bipolar I disorders as their main problem
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Personality Outpatient Unit, Section of Personality Psychiatry, Clinic for Mental Health and Addiction, Oslo University Hospital
Oslo, 4959 Nydalen, Norway
Related Publications (1)
Ulvestad DA, Johansen MS, Kvarstein EH, Pedersen G, Wilberg T. Minding mentalizing - convergent validity of the Mentalization Breakdown Interview. Front Psychiatry. 2024 Jun 21;15:1380532. doi: 10.3389/fpsyt.2024.1380532. eCollection 2024.
PMID: 38974920DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Theresa Wilberg, professor
Department of Research and Development, Oslo University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- senior consultant and professor
Study Record Dates
First Submitted
November 1, 2019
First Posted
November 8, 2019
Study Start
November 1, 2019
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
November 8, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share